From Forbes:
Drug developer Pfizer Inc. said Friday it will appeal a Canadian federal court decision denying its application to block approval of a generic version of the cholesterol-lowering drug Lipitor.
Indian generic drug maker Ranbaxy Pharmaceuticals Inc. is asking for approval of its version of Lipitor. The ruling deals with a patent that Pfizer (nyse: PFE - news - people ) said holds market exclusivity until July 2010. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Sunday, January 28, 2007
Pfizer to Appeal Canadian Decision
It will be interesting to see where this legal battle goes. I think we'll be hearing about this for most of 2007.
No comments:
Post a Comment